Team:ULB-Brussels/H2

From 2010.igem.org

(Difference between revisions)
(New page: {{ULB_Header_2}} <html><body> <div align="center"><table border="0"> <tr> <td><img src="https://static.igem.org/mediawiki/2010/3/33/ULBFleche_gauche.gif"></td> <td><a href="http://20...)
 
(7 intermediate revisions not shown)
Line 19: Line 19:
<p><br>
<p><br>
-
E. coli naturally produces hydrogen through the mixed acid fermentation. Our goal in this part of the project is to increase  the H2 production by modifying the carbon flow through the pathways of the mixed acid fermentation (MAF). The pathways of this fermentation are quite simple. Phosphoenolpyruvate (PEP), which comes from  the glucolysis, is transformed into pyruvate or into oxaloacetate. Those two molecules are then transformed into several products after a chain of reactions. Hydrogen is one of those products. It is produced from formate to regulate the intracellular pH of the bacteria <a href="#R1">[1]</a>.</p>
+
<em>E. coli</em> naturally produces hydrogen through the mixed acid fermentation. Our goal in this part of the project is to increase the H2 production by modifying the carbon flow through the pathway of the mixed acid fermentation (MAF). The pathways of this fermentation are quite simple. Phosphoenolpyruvate (PEP), which is produced by the glycolysis, is transformed into pyruvate or into oxaloacetate. Those two molecules are then transformed into several products after a chain of reactions. Hydrogen is one of those products. It is produced from formate to regulate the intracellular pH of the bacteria <a href="#R1">[1]</a>.</p>
-
<p>Here is a simplified global overview  of the mixed acid fermentation (see fig.1 below):<br>
+
<p>Here is a simplified global overview  of the mixed acid fermentation (fig.1):<br>
</p>
</p>
<div align="center"><table border="0" align="center">
<div align="center"><table border="0" align="center">
Line 31: Line 31:
</table></div>
</table></div>
-
<p> Each reaction is controlled by one or several enzymes. By overexpressing or deleting specific genes involved in the MAF, we expect to increase the production of hydrogen. The pathway in which we are interested in is this one (see fig. 2 below):</p>
+
<p> Each reaction is controlled by one or several enzymes. By overexpressing or deleting specific genes of the MAF pathway, we expect to increase the hydrogen production. The part of MAF pathway in which we are interested is indicated by red lines (fig. 2).</p>
<div align="center"><table border="0" align="center">
<div align="center"><table border="0" align="center">
   <tr>
   <tr>
Line 40: Line 40:
   </tr>
   </tr>
</table></div>
</table></div>
-
<p>        All the reactions crossing the red lines should be avoided or limited, and the three main reactions which lead to the production of hydrogen should be increased.<br>
+
<p>All the reactions crossing the red lines should be avoided or limited, and the three main reactions which lead to hydrogen production should be increased.
-
  The hydrogen is produce from formate by the formate hydrogenase lyase system (FHL), an intracellular membrane-bound complex composed of the formate dehydrogenase (FDHH) and the hydrogenase 3 [1]. This complex catalyzes the reaction:<br>
+
The hydrogen is produced from formate by the formate hydrogenase lyase system (FHL), an intracellular membrane-bound complex composed of the formate dehydrogenase (FDHH) and the hydrogenase 3  
-
  Formate + H+ &lt;=&gt; H2 + CO2<br>
+
<a href="#R1">[1]</a>. This complex catalyzes the following reaction:</p>
-
  Hydrogen is not excreted outside the bacteria  but it is immediately consumed by two uptake hydrogenases, the hydrogenase 1 and 2 following this reaction [1][2]:<br>
+
<p align="center"><br>
-
   A menaquinone  + H2 + 2H+ &lt;=&gt; A menaquinol + 2H+<br>
+
Formate + H+ &lt;=&gt; H2 + CO2</p>
-
The FHL system is activated by FhlA (formate hydrogen-lyase transcriptional activator), which is regulated by FNR and repressed by HycA [1]. FNR is the main transcriptional regulator that mediates the transition between aerobic and anaerobic growth through the regulations of hundreds of genes [2]. All the regulations linked to the transformation of formate into hydrogen are shown here (see fig.3 below):</p>
+
<p><br>
 +
Hydrogen is not excreted outside of the cell but it is immediately consumed by two uptake hydrogenases, the hydrogenase 1 and 2 <a href="#R1">[1]</a><a href="#R2">[2]</a>:</p>
 +
<p align="center"><br>
 +
   A menaquinone  + H2 + 2H+ &lt;=&gt; A menaquinol + 2H+</p>
 +
<p><br>
 +
The expression of the FHL system is activated at  the level of transcription by the FhlA activator (formate hydrogen-lyase transcriptional activator). Expression of <em>fhlA</em> is positively regulated by FNR and repressed by HycA <a href="#R1">[1]</a>. FNR is the main transcriptional regulator that mediates the transition between aerobic and anaerobic growth through the regulation of hundreds of genes <a href="#R2">[2]</a>. All the regulations linked to the transformation of formate into hydrogen are shown here (fig.3):</p>
<p><br>
<p><br>
</p>
</p>
Line 57: Line 62:
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><br>
<p><br>
-
   <gh2>Genes to delete</gh2>
+
   <gh2>MAF pathway modification: genes to delete</gh2>
</p>
</p>
<p><br>
<p><br>
-
  Several reactions in the MAF are irrelevant to  hydrogen production (see figure 2 above). To disable these reactions we have to delete the genes which code for the enzymes  catalyzing those reactions. <br>
+
Several steps of the MAF pathway are irrelevant for hydrogen production (fig. 2). To inactivate these reactions, the genes encoding enzymes that catalyze these reactions have to be deleted using the technique described in the homologous recombination module.
-
  We studied a lot of articles about producing H2  through the MAF. Based on that, we decided which genes we would overexpress and which we would disrupt. <br>
+
After exhaustive analyzes of the literature, we decided which genes we would overexpress and which we would disrupt.  
-
Here is the list of all the genes that we planned to delete. By using the KEIO Collection database, we checked that none of those genes were essential to the bacteria <a href="#R4">[4]</a>.</p>
+
Here is the list of all the genes that we planned to delete. By using the KEIO Collection database, we checked that none of those genes were essential  
-
<ol start="1" type="1">
+
<a href="#R4">[4]</a>.</p>
-
  <li><strong>PPC</strong><strong> </strong></li>
+
-
</ol>
+
-
<p>The gene ppc codes for the phosphoenolpyruvate  carboxylase (Ppc). This enzyme catalyzes the reaction <a href="#R2">[2]</a>:<br>
+
-
  Phosphoenolpyruvate + CO2 + H2O &lt;=&gt; Oxaloacetate  + Phosphate + H+<br>
+
-
  Deleting ppc will therefore prevent the PEP  being transformed into oxaloacetate which is not interesting for us. As shown  on figures 1 and 2, the left wing of the mixed acid fermentation does not lead  to hydrogen production. This wing starts with the transformation of PEP into oxaloacetate.  The deletion of ppc will therefore disable this pathway and all the PEP will be  transformed into pyruvate.</p>
+
<ul>
<ul>
-
   <li><strong>LdhA</strong></li>
+
   <li><strong>ppc</strong>
</ul>
</ul>
-
<p align="left">Pyruvate is transformed into  (R)-lactate or into formate + acetyl-CoA but only this second reaction is  interesting for us. We must therefore disable the first one. LdhA is the gene coding for the D-lactate dehydrogenase which catalyze the following reaction:<br>
+
<p>The <em>ppc</em> gene encodes the phosphoenolpyruvate carboxylase enzyme (Ppc). This enzyme catalyzes the following reaction <a href="#R2">[2]</a>:</p>
-
   NADH + Pyruvate + H+ &lt;=&gt; NAD+ + (R)-lactate<br>
+
<p align="center"><br>
-
  Deleting ldha should ensure that all the pyruvate should be transformed into formate + acetyl-CoA.</p>
+
   Phosphoenolpyruvate + CO2 + H2O &lt;=&gt; Oxaloacetate  + Phosphate + H+</p>
 +
<p><br>
 +
Deletion of the <em>ppc</em> gene will therefore prevent the PEP to be transformed into oxaloacetate which is not interesting for our application. As shown on figures  1 and 2, the left part of the MAF pathway does not lead to hydrogen production.  Thus, deletion of <em>ppc</em> will inactivate  this part of the pathway and all the PEP will be transformed into pyruvate.</p>
<ul>
<ul>
-
   <li><strong>FocA</strong></li>
+
   <li><strong>ldhA</strong></li>
</ul>
</ul>
-
<p>FocA codes for a formate transporter of the plasmic membrane which excreted formate outside the cell. It has been shown that disabling this transporter increase the intracellular concentration of formate <a href="#R5">[5]</a>. Higher formate concentration inside the cell is obviously interesting for  hydrogen production.</p>
+
<p align="center">Pyruvate is transformed into (R)-lactate or into formate + acetyl-CoA. The second reaction is interesting for our application. The first reaction is mediated by the D-lactate dehydrogenase (LdhA) which catalyzes the following reaction:</p>
 +
<p align="center"><br>
 +
  NADH + Pyruvate + H+ &lt;=&gt; NAD+ + (R)-lactate</p>
 +
<p align="center"><br>
 +
Deletion of <em>ldhA</em> should ensure that all the pyruvate is transformed into formate + acetyl-CoA.</p>
<ul>
<ul>
-
   <li><strong>HyaB</strong></li>
+
   <li><strong>focA</strong></li>
</ul>
</ul>
-
<p>To prevent hydrogen uptake by the two  hydrogenases, HyaB and HybC, we have to disable them. Both hydrogenases are  coded by an operon. The HyaB operon is composed of 6 genes (from HyaA to HyaF),  hyaB coding for the largest subunit of the hydrogenase [2]. This subunit is  required for the hydrogenase to be functional<a href="#R2"> [2]</a>. Deleting this subunit should disable the hydrogenase 1 <a href="#R1">[1]</a>.</p>
+
<p>The <em>focA</em> gene encodes for a formate transporter located in the plasmic membrane. FocA  transports formate outside the cell. It has been shown that disabling this transporter increases the intracellular formate concentration  <a href="#R5">[5]</a>. A higher formate intracellular concentration is  obviously interesting for hydrogen production.</p>
<ul>
<ul>
-
   <li><strong>HybC</strong></li>
+
   <li><strong>hyaB and hybC</strong> </li>
</ul>
</ul>
-
<p>The second hydrogenase is coded by an operon of 7 genes (from HybA to HybG), HybC coding for the largest subunit of the second hydrogenase. As for HyaB, deleting the largest subunit of the hydrogenase  should disable it <a href="#R1">[1]</a>.</p>
+
<p>To prevent hydrogen uptake by the two hydrogenases, HyaB and HybC, we have to inactivate them. Both hydrogenases-encoding genes are located in operons.
 +
The hya operon is composed of 6 genes (from hyaA to hyaF). The hyaB gene encodes the largest subunit of the hydrogenase <a href="#R2"> [2]</a>. This subunit is  required for the hydrogenase to be functional<a href="#R2"> [2]</a>. Deleting this gene should inactivate the hydrogenase 1 <a href="#R1">[1]</a>.</p>
 +
<p>The second hydrogenase-encoding gene is located in an operon composed of 7 genes (from hybA to hybG). The hybC gene encodes the largest subunit of the second hydrogenase. As for hyaB, deleting the gene encoding the largest subunit should inactivate it <a href="#R1">[1]</a>.</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><gh2>Materials and methods</gh2>
<p><gh2>Materials and methods</gh2>
</p>
</p>
-
<p><br>
+
<p>&nbsp;</p>
-
   In order to delete  the five genes listed above, we used a method based on the λ phage Red  recombinase (see chapter X). It consists in  producing a gene-specific PCR fragments, containing an antibiotic resistance gene. The targeted gene is replaced by the resistance gene through homologous recombination performed by the Red recombinase system, and finally the  resistance is removed.All the primers used for the  deletions of the 5 genes are listed in Table 1 at the end of this chapter.<br>
+
<ol>
-
  Both chloramphenicol and kanamicine resistance cassette already contain the FRT  sequence required to remove the resistance after a successful deletion (see chapter X about the homologous recombination) <br>
+
   <li><u>Gene  deletion by the λ phage Red system</u></li>
-
  The antibiotic resistance will help us to select the bacteria in which the targeted gene has been successfully disrupted. To delete a gene, we simply had to electroporate  the cells with the PCR product   and then  spread them on a selective medium containing the appropriate antiobiotic. In  order to achieve the deletion by homologous recombination, the cells must be transformed with the plasmid helper λ (PH λ). We had to streak three times the deletion candidates on agar plate with the appropriate antibiotic, in order to purify their genome. A bacteria has numerous copies of each of its genes. The  streaking process on a selective medium has for objective to eliminate the wild type version of the surnumerous chromosomes. After this process, we tested our deletion candidate by PCR. We amplified the area of the deletion and by  measuring the obtained sequence (by electrophoresis), we were able to verify if  the expected deletion has happened or not. If the sequence amplified has the length of the wild type, the deletion failed, but if the sequence has the  length of the resistance cassette, the gene has been successfully deleted.<br>
+
 
-
   The next step is to remove the resistance cassette using the flippase recombination enzyme (see chapter X about homologous recombination). The  flippase will recognize the FRT (flippase recognition target) sequence placed  at each ends of the resistance cassette and will delete what is in between the  two FRT sequences. Once the cassette has been removed, we a single deletion mutant. We can start the deletion process from the start for another gene to obtain a two deletion mutant. <br>
+
<p>In order to delete  the five genes listed above, we used a method based on the λ phage Red system. As this method is described in great details in the &lsquo;homologous recombination  module&rsquo;, we will briefly summarize it here. This method consists in the production of a gene-specific PCR fragment which contains an antibiotic  resistance gene and site-specific recombination sites (FRT) flanking this gene.  This PCR fragment is then electroporated in a strain containing the plasmid  helper λ (PH λ) (see homologous recombination module). This plasmid encodes the  genes of the Red system. The target gene is replaced by the resistance gene through homologous recombination using the Red system. We worked with two different antibiotic resistances: chloramphenicol (cm) and kanamicine (kan).<br>
-
To avoid losing too much time, we proceeded to the different deletions in parallel. The single gene mutations in the different resulting strains were then combined using P1 transduction. That is the reason why we used two  different resistance cassettes (chloramphenicol and kanamicine). Once we have  two different strains of bacteria, each with one gene deleted and the resistance cassette still in place, we can combined them using P1 transductionTwo different resistance cassettes are needed in order to select the two  deletion mutant on a selective medium. The selective medium contains the two antibiotics. </p>
+
The antibiotic resistance  cassette is eventually removed by site-specific recombination using the Flp recombinase. This method leads to the &lsquo;clean&rsquo; deletion of the gene of interest without any traces of antibiotic resistance gene. It is also adapted to delete genes in operons since the resistance-FRT cassettes used in this work also contain translation signal (RBS). This allows a proper expression of the genes  downstream of the deletion (no polar effect). The primers used deleting the 5 genes of interest are listed in Table 1.  </p>
 +
 
 +
   <li><u>Phage P1 transduction</u></li>
 +
 
 +
<p>P1vir stock&nbsp;:<br>
 +
  Overnight cultures of the donor strain are  diluted 100 fold in 20 ml of LB medium supplemented with MgSO4 10-2M  and of CaCl2 5.10-3M and grown at 37°C. At an optical density at  600nm of 0.2, 10µl of a P1 vir stock is added (approximately 109  pfu/ml). Once the bacteria are lysed, 1/20 (v/v) of chloroform is added and the  culture is vigorously shacked. The mix is centrifuged at 4°C at 3,700 g and the supernatant is conserved at 4°C. 1/20 of the total volume of chloroform is  added and vigorously shacked, then centrifuged again in the same conditions. The surnageant containing the P1 particles is stored at 4°C. <br>
 +
  P1vir transduction :<br>
 +
  Overnight culture of the recipient strain is pelleted and resuspended in the same volume of MgSO4 10-2M and of CaCl2 5.10-3M. To 100µl of the resuspended pellet, 100µl and 10µl of the P1 lysat is added. The mix is conserved 30 min at 37°C. 3 ml of agar 0.7% is added as well as 100µl of Na citrate 1M. The entire mix is plated on selective plates at 37°C for 16h. The candidates are streaked 3 times on  selective plates and a PCR is then performed to confirm the transduction of the  marker of interest.  </p></ol>
 +
<p>&nbsp;</p>
<p><br>
<p><br>
   <gh2>Results</gh2>  
   <gh2>Results</gh2>  
</p>
</p>
 +
<p>&nbsp;</p>
 +
    <li><u>Deletion  of the <em>ldhA</em> gene by homologous recombination</u></li>
<p><br>
<p><br>
-
   In  the laboratory, we only managed to obtain a three deletion mutant. The construction of the resistance cassettes for each gene by PCR took us a little more than a week. Because of the size of the primers used, we had to try several times those PCR. Once we had our resistance cassettes, it took us about 1 month to obtain our first deletion candidate. The process of electroporation for  deletions is not really efficient. We obtained a lot of deletion candidate (i.e. we obtained a lot of bacteria which grew on the selective medium). As explained in the materials and methods part, we had to streak three times each  candidate (this process takes therefore 3 days). Unfortunately the candidates often were negative: we assumed that the resistance cassette was inserted at a  wrong space in the genome, giving the bacteria the resistance but without deleting the aimed gene. Once we had two different strains, each one with a  different resistance cassette for a different deleted gene, we were able to  start the transduction process. By the time we finally had our three deletion mutant; it was too late for a measurement campaign.</p>
+
   The amplification of the resistance cassettes with  the primers specific to our 5 genes of interest by PCR took us a little more than a week. Because of the size of the primers used, we had to try several times the PCR and vary the parameters. <br>
 +
Here is the picture of the electrophoresis of  those PCR for the 5 genes: </p>
 +
<table border="0" align="center">
 +
  <tr>
 +
    <td align="center"><p><img src="https://static.igem.org/mediawiki/2010/7/77/ULBH2_(1).png"><br>
 +
      <leg></leg>
 +
    </p></td>
 +
  </tr>
 +
</table>
 +
<p><gh2></gh2>
 +
  For each genes we tried to obtain both  chloramphenicol (about 1100bp) and kanamicine (about 1500bp) resistance cassettes. From left to right we have the genes <em>ldhA</em> (1 and 2), <em>focA</em> (4  and 5), <em>ppc</em> (7 and 8), <em>hybC</em> (10 and 11) and <em>hyaB</em> (13 and 14). The sinks 3, 6, 9, 12  and 15 are the five negative controls.<br>
 +
        Once  we obtained these cassettes, it took us about 1 month to obtain our first deletion candidate. The electroporation efficiency of the MG1655/PHl strain was not good. We obtained a lot of false-positive deletion  candidates (i.e. clones growing on the selective medium). As explained in the homologous  recombination module, we had to purify at least three times each candidate (this process takes therefore at least 3 days) before checking the  deletion/insertion of the resistance cassette. Using primers complementary to  the flanking regions of the genes of interest, PCR were performed on candidate  colonies (data shown below). Unfortunately, the candidates were most of the time  wild-type for the gene of interest. Our hypothesis is that the resistance cassette was inserted at another location in the genome. The reason for that is  unknown since the genes of interest are not essential for <em>E. coli</em> viability, at least in the conditions we used.  <br>
 +
After  several weeks of unsuccessful attempts, we finally obtained the MG1655 <em>D</em><em>ldhA::cm</em> strain.
 +
Here is the picture of the  electrophoresis where we tested different deletion candidates:</p>
 +
<table border="0" align="center">
 +
  <tr>
 +
    <td align="center"><p><img src="https://static.igem.org/mediawiki/2010/9/90/ULBH2_(2).png"><br>
 +
      <leg></leg>
 +
    </p></td>
 +
  </tr>
 +
</table>
 +
<p>The sinks we are interested in are the 4 first  ones. The wild type version of the gene <em>ldhA</em> is in the third sink. The two first sinks are the deletion candidates for <em>ldhA </em>with the cm resistance cassette<em>.</em> The fourth sink is the negative control for this gene. For information, the other sinks are the tests for the 4  other genes: 5 and 6 are the deletion candidates for ppc; 9 and 10 are the  deletion candidates for focA; 17 and 18 are the deletion candidates for hybC:  21 and 22 are the deletion candidates for hyaB. Unfortunately, the cm  resistance cassette (about 1100 bp) and the gene <em>ldhA</em> (990 bp) have approximately the same length. In order to  testify if we really had the MG1655 <em>D</em><em>ldhA::cm</em> strain, we did a test with a restriction enzyme which cut the gene <em>ldhA.</em> <br>
 +
The result of this test is shown here:</p>
 +
<table border="0" align="center">
 +
  <tr>
 +
    <td align="center"><p><img src="https://static.igem.org/mediawiki/2010/2/28/ULBH2_(3).png"><br>
 +
      <leg></leg>
 +
    </p></td>
 +
  </tr>
 +
</table>
 +
<p>After the purification process, we had 4 candidates  for the MG1655 <em>DldhA::cm</em> strain. For those 4 candidates, we did a PCR on  the gene <em>ldhA </em>(not knowing if it  really was <em>ldhA</em> or the cm resistance cassette that we amplified) and we digest the product of the PCR with an enzyme  which cut <em>ldhA.</em> The digested gene <em>ldhA</em> is in the sink 7, the digested cm  resistance cassette is in the sink 6. The four digested candidates are in the 4  first sinks. The result is therefore a success, because the candidates are not  digested like <em>ldhA</em>. The wild-type  version of the gene has been successfully replaced with the cm resistance  cassette. We have our MG1655 <em>DldhA::cm</em> strain.</p>
 +
<ul>
 +
  <li><u>Construction  of the MG1655</u><em><u> D</u></em><em><u>ppc::kan</u></em><u>, MG1655</u><em><u> D</u></em><em><u>focA::kan</u></em><u>, MG1655</u><em><u> D</u></em><em><u>hyaB::kan</u></em><u>, MG1655 </u><em><u>D</u></em><em><u>ldhA::cm</u></em><u> </u><em><u>D</u></em><em><u>ppc::kan</u></em><u>, MG1655 </u><em><u>D</u></em><em><u>ldhA::cm</u></em><em><u> D</u></em><em><u>focA::kan </u></em><u>andMG1655 </u><em><u>D</u></em><em><u>ldhA::cm</u></em><em><u> D</u></em><em><u>hyaB::kan</u></em><u> mutant strains by P1  transduction</u></li>
 +
</ul>
 +
<p>By  that time, we obtained the KEIO strains deleted for our 5 genes of interest. We  were thus able to make a P1 stock on these strains (see materials and methods) and to transduce the <em>D</em><em>ppc::kan</em>, <em>D</em><em>focA::kan</em>, <em>D</em><em>hyaB::kan</em> and <em>D</em><em>hybC::kan</em> markers in the  MG1655 wild-type strain and in the MG1655 <em>D</em><em>ldhA::cm</em> strain.  We obtained 6 mutant strains: the single MG1655<em> D</em><em>ppc::kan</em>, MG1655<em> D</em><em>focA::kan</em> and MG1655<em> D</em><em>hyaB::kan</em> mutant strains as  well as the double MG1655 <em>D</em><em>ldhA::cm</em> <em>D</em><em>ppc::kan</em>, MG1655 <em>D</em><em>ldhA::cm</em><em> D</em><em>focA::kan </em>andMG1655 <em>D</em><em>ldhA::cm</em><em> D</em><em>hyaB::kan</em> mutant strains.  These strains were checked by PCR.  <br>
 +
  The results are shown here:</p>
 +
<table border="0" align="center">
 +
  <tr>
 +
    <td align="center"><p><img src="https://static.igem.org/mediawiki/2010/5/5e/ULBH2_(4).png"><br>
 +
      <leg></leg>
 +
    </p></td>
 +
  </tr>
 +
</table>
 +
<p>&nbsp;</p>
 +
<p>For  each strain tested, we have: four candidates, one negative control and the wild  type version of the gene that is supposed to have been deleted. If the  amplified DNA segment of a candidate has the size of the reistance cassette instead  of the size of the wild type version of the gene, the candidate is a mutant.  Here are the results:</p>
 +
<ul>
 +
  <li>From 1 to  6 is the test for the MG1655<em> D</em><em>hyaB::kan</em> mutant:  the 4 candidates are mutants. </li>
 +
  <li>From 8 to 13 is the test for the MG1655 <em>D</em><em>ldhA::kan </em>mutant: the  candidates in the sinks 10 and 11 are mutants.</li>
 +
  <li>From 17 to 22 is the test for the gene <em>ldhA</em> of the double MG1655 <em>D</em><em>ldhA::cm</em> <em>D</em><em>ppc::kan </em>mutant: the 4  candidates are mutants.</li>
 +
  <li>From 24 to 29 is the test for the gene <em>ldhA</em> of the double MG1655 <em>D</em><em>ldhA::cm</em><em> D</em><em>focA::kan </em>mutant:  the 4 candidates are mutants.</li>
 +
  <li>From 33 to 38 is the test for the gene focA of the  double MG1655 <em>D</em><em>ldhA::cm</em><em> D</em><em>focA::kan </em>mutant:  the candidates in the sinks 35 and 36 are mutants.</li>
 +
  <li>From 40 to 45 is the test for the gene <em>ppc</em> of the double MG1655 <em>D</em><em>ldhA::cm</em> <em>D</em><em>ppc::kan </em>mutant: the  candidates in the sinks 40, 42 and 43 are mutants.</li>
 +
</ul>
 +
<p>        We  managed to obtain different double mutant strains, ready for another  transduction. Unfortunately, due to the lack of time we were unable to continue our progression and we were also unable to characterize the double mutant strains for growth in different medium, at different temperature, …</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
-
<p><gh2>Genes  to overexpress</gh2>
 
-
</p>
 
<p><br>
<p><br>
-
   In order to enhance  hydrogen production, we decided to over-express some genes involved in the  hydrogen production. In the mixed acid fermentation, there are three reactions which interest us: </p>
+
   <gh2>MAF pathway modification: Genes to overexpress</gh2>
 +
</p>
 +
<p>&nbsp;</p>
 +
<p>In order to enhance  hydrogen production, we proposed to over-express some genes involved in the  hydrogen production. Three steps in the mixed acid fermentation pathway are of interest:  
<ul>
<ul>
   <li>The  transformation of phosphoenolpyruvate into pyruvate:</li>
   <li>The  transformation of phosphoenolpyruvate into pyruvate:</li>
</ul>
</ul>
-
<p>Phosphoenolpyruvate + ADP + 2H+ &lt;=&gt; Pyruvate + ATP<br>
+
<p align="center">Phosphoenolpyruvate + ADP + 2H+ &lt;=&gt; Pyruvate + ATP <br></p><p>
-
   This reaction happens in  other pathways, so we decided not to improve it assuming it won’t be the limiting reaction.</p>
+
   This reaction is present in  other pathway. We thus decided not to improve it assuming it will not be the limiting step.</p>
<ul>
<ul>
   <li>The  transformation of pyruvate into formate:</li>
   <li>The  transformation of pyruvate into formate:</li>
</ul>
</ul>
-
<p>Pyruvate + Coenzyme A &lt;=&gt; Formate + Acetyl-CoA<br>
+
<p align="center">Pyruvate + Coenzyme A &lt;=&gt;  Formate + Acetyl-CoA <br></p><p>
-
   This reaction is catalyzed  by two pyruvate formate lyase: pflB and tdcE. The formate is the key molecule  for hydrogen production and high levels of formate concentration inside the cell are needed for hydrogen production <a href="#R6">[6]</a>. </p>
+
   This reaction is catalyzed  by two pyruvate formate lyase: PflB and TdcE. The formate is the key molecule  for hydrogen production and intracellular elevated formate concentration is needed for an efficient hydrogen production <a href="#R6">[6]</a>. </p>
<ul>
<ul>
   <li>The  transformation of formate into hydrogen:</li>
   <li>The  transformation of formate into hydrogen:</li>
</ul>
</ul>
-
<p>Formate + H+ &lt;=&gt; CO2 + H2<br>
+
<p align="center">Formate + H+ &lt;=&gt;  CO2 + H2 <br></p>
-
   This reaction is under the  control of the FHL complex (formate hydrogenase lyase). As explained earlier, the FHL complex is regulated by FNR, a transcriptional regulator that mediates the transition between aerobic and anaerobic growth, and repressed by HyaC. In studies, we find that the activity of the FHL complex is not the limiting process for hydrogen production. We, therefore, choosed not to over-express the two enzymes of the FHL complex: the formate dehydrogenase (FDHH) and  the hydrogenase 3<a href="#R2">[2]</a>.<br>
+
   <p>This reaction is under the  control of the FHL complex (formate hydrogenase lyase composed of the formate dehydrogenase  (FDHH) and the hydrogenase 3). As stated above, the FHL complex is regulated by FNR, a transcriptional regulator that mediates the transition between aerobic and anaerobic growth, and repressed by HyaC. It has been showed that FHL activity is not the limiting step for hydrogen production. We decided  not to over-express the two enzymes of the FHL complex <a href="#R3">[3]</a>.<br>
-
   On the basis of those three  reactions, we decided to overexpress the following genes:</p>
+
   On the basis of these three  reactions, we decided to overexpress the following genes:</p>
<ul>
<ul>
-
   <li><strong>FNR</strong></li>
+
   <li><strong><em>fnr</em></strong></li>
</ul>
</ul>
-
<p>        FNR is quite an obvious choice for the first gene to overexpress. FNR is the main transcriptional regulator that mediates the transition from aerobic to anaerobic growth <a href="#R2">[2]</a>. The concentration of the protein FNR is the same under aerobic and anaerobic conditions, but in presence of O2 the protein FNR is inactivated. Under anaerobic conditions, the protein became functional and activates hundreds of genes involved in anaerobic metabolism. FNR also represses genes  involved in aerobic metabolism <a href="#R2">[2]</a>. Over-expressing the gene FNR should increase the concentration level of the protein FNR and should thus enhance all the anaerobic metabolism of the bacteria. The three reactions of the mixed acid  fermentation leading to hydrogen will therefore be increased.</p>
+
<p>        <em>fnr</em> is quite an obvious choice for the first gene to overexpress. FNR is the main transcriptional regulator that mediates the transition from aerobic to anaerobic growth <a href="#R2">[2]</a>. The concentration of the FNR protein is similar  under aerobic and anaerobic conditions. The regulation occurs at the level of FNR  activity: in the presence of O2, FNR is inactivated. Under anaerobic conditions, FNR is functional and activates expression of hundreds of genes involved in anaerobic metabolism. In these conditions, FNR represses genes  involved in aerobic metabolism <a href="#R2">[2]</a>. Over-expressing the <em>fnr</em> gene should increase FNR concentration and should thus enhance  the anaerobic metabolism. The three reactions of the mixed acid fermentation pathway leading to hydrogen described above should therefore be increased.</p>
<ul>
<ul>
-
   <li><strong>PflB</strong></li>
+
   <li><strong><em>pflB</em></strong></li>
</ul>
</ul>
-
<p>        PflB codes for one of the two pyruvate formate lyases which catalyze the transformation of pyruvate into formate <a href="#R2">[2]</a>. This reaction is the most important one for hydrogen production. Overexpressing PflB should assure sufficient concentration levels of formate  inside the cell for hydrogen production. The pyruvate is also used in many  other reactions, but we want the maximum of pyruvate to be used for hydrogen production.</p>
+
<p>        The <em>pflB</em> gene encodes one of the two pyruvate formate lyases which catalyze the transformation of pyruvate into formate <a href="#R2">[2]</a>. This reaction is the most important one for hydrogen production. Over-expressing <em>pflB</em> should increase formate concentration and therefore hydrogen production. Although pyruvate is the substrate for many  other reactions, high level of PflB should direct pyruvate to formate synthesis and therefore hydrogen production.</p>
<ul>
<ul>
-
   <li><strong>TdcE</strong></li>
+
   <li><strong><em>tdcE</em></strong></li>
</ul>
</ul>
-
<p>        TdcE codes for the second pyruvate formate lyase <a href="#R2">[2]</a>. The reasons to overexpress this gene are the same as for PflB.</p>
+
<p>The <em>tdcE</em> gene encodes the second pyruvate formate lyase <a href="#R2">[2]</a>. The reasons to overexpress this gene are the same as for <em>pflB</em>.</p>
-
<p>&nbsp;</p>
+
<p><gh2>Materials  and methods</gh2></p>
-
<p><gh2>Materials  and methods</gh2>
+
-
</p>
+
<p><br>
<p><br>
-
   To over-express those three  genes, we decide to insert them into to plasmid pSB1C3 with a strong RBS, a constitutive promoter and a terminator. First of all, we had to obtain the three genes in order to link them with the RBS, the promoter and the terminator.  We decided to work in the BioBrick standard assembly 10 because the plasmid  pSB1C3 is only compatible with this one. Unfortunately, FNR is cut by EcoR1,  and cannot be used without modifying its sequence. We introduce a silent mutation in the restriction site of EcoR1 and we ordered our modified gene of FNR on mrgene.com. TdcE was obtained by PCR using primers of the gene on the  wild type genome of E. coli. PflB is also cut by a restriction enzyme of the standard assembly 10: Pst1. We could have also introduced a silent mutation in this gene and order it on mrgene.com, but due to the length of Pflb (2283 bp) and our limited budget, we were not able to afford it.<br>
+
   To over-express these three  genes of interest, we decided to insert them into plasmid pSB1C3 with a strong RBS, a constitutive promoter and a terminator. We decided to work in the  BioBrick standard assembly 10 because it is compatible with pSB1C3.  <br>
-
   The RBS, the promoter and  the terminator chosen are the strongest ones received in spring 2010 distribution.<br>
+
  First of all, we had to obtain the three genes to ligate them with the RBS, the promoter and the terminator. Unfortunately, the <em>fnr</em> gene contains an EcoR1 restriction site. Therefore, we had to introduce a  silent mutation in the sequence of this restriction site and ordered the modified <em>fnr</em> on mrgene.com. <br>
 +
  The <em>tdcE</em> gene was obtained by PCR using specific primers and the wild-type genome of <em>E. coli</em>. <br>
 +
  The <em>pflB</em> sequence contains a restriction enzyme present in the standard assembly 10: Pst1. We could have also introduced a silent mutation in this sequence  and ordered it on mrgene.com. However, due to the size of the <em>pflb</em> gene (2283 bp) and our limited budget, we were not able to afford it.<br>
 +
   The RBS, the promoter and  the terminator that were selected are the same for the three genes and are  described as being the &lsquo;strongest&rsquo; ones received in spring 2010 distribution.<br>
   The promoter is: BBa_J23100 <br>
   The promoter is: BBa_J23100 <br>
   The RBS is: BBa_B0034<br>
   The RBS is: BBa_B0034<br>
   The terminator is: BBa_B0024<br>
   The terminator is: BBa_B0024<br>
-
   When we had the genes, we linked them to the RBS by digesting the plasmid of the RBS using the enzyme Spe1 and Pst1 (in order to open the plasmid behind the RBS sequence). The genes were digested by Xba1 and Pst1. Then we linked the two parts together using ligation enzymes. We started this process again to insert the part RBS+gene with the promoter. The next step consists in extracting the construction promoter+RBS+gene and inserting it in front of the terminator. Finally, we have to extract the construction promoter+RBS+gene+terminator and insert it into the pSB1C3. <br>
+
   After obtaining the gene sequences either by PCR or by <em>in vitro</em> synthesis, the plan was to ligated them into the plasmid containing the RBS  opened with Spe1 and Pst1 in order to clone the genes downstream of the RBS. The genes were also digested by Xba1 and Pst1. The second step was to ligate the part RBS + gene with the promoter. The third step consisted in extracting the construction promoter + RBS + gene and inserting upstream of the terminator. The last step was to extract the promoter+RBS+gene+terminator and insert it into the pSB1C3 plasmid. <br>
-
Unfortunately, we did not have had the time the complete the all process. We only managed to link the  gene to the RBS. </p>
+
  Unfortunately, due to lack of time, we were unable to do all these constructs.<br>
-
<p>&nbsp;</p>
+
  We managed to obtain the  gene <em>tdcE</em> by PCR as we can see here:</p>
 +
<table border="0" align="center">
 +
  <tr>
 +
    <td align="center"><p><img src="https://static.igem.org/mediawiki/2010/d/d1/ULBH2_(5).png"><br>
 +
      <leg></leg>
 +
    </p></td>
 +
  </tr>
 +
</table>
 +
<p>The gene <em>tdcE</em> is in the sink 3  and 5. The two sinks correspond to two different PCR programs. The sinks 2 and  4 are the negative controls for those PCR.<br>
 +
           We digested <em>tdcE</em> and inserted it in the pSB1C3 to  send it as a BioBrick: BBa_K348000.
<p><br>
<p><br>
-
   <gh2>Other  genes considered</gh2>
+
   <gh2>Genes of the MAF pathway that we did not consider</gh2>
-
</p>
+
<p>&nbsp;</p>
<p>&nbsp;</p>
-
<p><br>
+
<p>Several other genes of the MAF pathway could have been potential candidates for modifications (deletion or overexpression). However, after  exhaustive literature readings, we did not consider them.   
-
  Several other genes are involved in the MAF and are potential candidates for modifications (deletion or overexpression). We listed below all the other genes considered for modification:</p>
+
<ol>
-
<ul>
+
   <li><strong><em>hycA</em></strong></li>
-
   <li><strong>HycA</strong></li>
+
 
-
</ul>
+
<p>        This gene encodes HycA, a regulator of the hydrogenase 3 in the FHL system <a href="#R2">[2]</a>. This regulator limits the amount of hydrogenase 3 in the cell. Deleting <em>hycA</em> should therefore lead to an increase of the concentration of hydrogenase 3. Note that as stated above, the hydrogenase 3 catalyzes the  transformation of formate into hydrogen. We did not consider this candidate since transformation of formate into hydrogen do not appear to be the limiting  step for hydrogen production and normal concentration of hydrogenase 3 is fully adequate<a href="#R3">[3]</a>. </p>
-
<p>        This gene codes for HycA, a regulator of the hydrogenase 3 in the FHL system <a href="#R2">[2]</a>. The regulator limits the amount of hydrogenase 3 in the cell. Deleting HycA  should therefore lead to an increase of the concentration of hydrogenase 3. And  as explained in the beginning of this chapter, the hydrogenase 3 catalyzes the  transformation of formate into hydrogen. But a study about the hydrogenase 3 has shown that, the transformation of formate into hydrogen is not the limiting  step for hydrogen production and that normal concentration of hydrogenase 3 is  fully adequate <a href="#R2">[3]</a>. We decided not to delete this gene based on that  information on to focus on the limiting steps of hydrogen production.</p>
+
 
-
<ul>
+
   <li><strong><em>aceE</em></strong><strong></strong></li>
-
   <li><strong>AceE</strong></li>
+
 
-
</ul>
+
<p>        This gene encodes a subunit of the pyruvate dehydrogenase complex. This complex catalyzes the following reaction <a href="#R2">[2]</a>:<br>
-
<p>        This gene codes for a subunit of the pyruvate dehydrogenase complex. This complex catalyzes the following reaction <a href="#R2">[2]</a>:<br>
+
   Pyruvate + NAD+ +  coenzyme A &lt;=&gt; Acetyl-CoA + CO2 + NADH<br>
   Pyruvate + NAD+ +  coenzyme A &lt;=&gt; Acetyl-CoA + CO2 + NADH<br>
-
   Or what we want for  hydrogen production is the transformation of pyruvate into formate. Unfortunately, AceE catalyzes other reactions, and deleting it reduces the  survivability and the growth rate of E. coli <a href="#R1">[1]</a>. We therefore decided not to delete this gene. This decision led us to focus on the transformation of  pyruvate into formate. That’s another reason why we decided to overexpress the gene TdcE (see above).</p>
+
   For hydrogen productiontransformation of pyruvate into formate is needed. The AceE enzyme catalyzes a  variety of reactions, and deleting the corresponding gene reduces <em>E. coli</em> viability <a href="#R1">[1]</a>. We therefore decided not to delete this gene. We focused on the transformation of pyruvate into formate and to overexpress the <em>tdcE</em> gene (see above).</p>
-
<ul>
+
 
-
   <li><strong>PoxB</strong></li>
+
   <li><strong><em>poxB</em></strong></li>
-
</ul>
+
 
-
<p>        PoxB is coding for a  pyruvate oxydase, which catalyze the transformation of pyruvate into acetate  and CO2  <a href="#R1">[1]</a>. This reaction consumes pyruvate which is the opposite  of what we want. We could have deleted poxB but we did not because the  transformation of pyruvate into acetate and CO2 is a very slow  reaction <a href="#R2">[2]</a>. The pyruvate oxydase pathway is even less important under anaerobic conditions <a href="#R2">[2]</a>. We also found, in a study, that deleting poxB did not  increased hydrogen production <a href="#R1">[1]</a>.</p>
+
<p>        The <em>poxB</em> gene encodes a pyruvate oxydase, which catalyzes the  transformation of pyruvate into acetate and CO2 <a href="#R1">[1]</a>. It has been described that deleting <em>poxB</em> does not  increase hydrogen production <a href="#R1">[1]</a>.</p>
-
<ul>
+
 
-
   <li><strong>FocB</strong></li>
+
   <li><strong><em>focB</em></strong></li>
-
</ul>
+
 
-
<p>        FocB codes for another  formate transporter (the other formate transporter is focA, see above). Unlike focA, focB is less efficient and less specific to formate. We could have deleted focB aswell but deleting the two formate transporter would have reduced the growth rate of our bacteria  <a href="#R1">[1]</a>. We, therefore, decided not to delete focB.</p>
+
<p>        FocB is a formate transporter (the other formate transporter is FocA, see above). Unlike FocA, FocB  is less efficient and less specific to formate. We could have deleted <em>focB</em> as well but deleting the two formate transporter would have reduced the growth rate<a href="#R1">[1]</a>. </p>
-
<ul>
+
 
-
   <li><strong>FdoG and fdnG</strong></li>
+
   <li><strong><em>fdoG</em></strong><strong> and <em>fdnG</em></strong></li>
-
</ul>
+
 
-
<p>        FdoG codes for formate dehydrogenase-O and fdnG for the formate dehydrogenase-N. Those two formate dehydrogenase catalyze the transformation of formate into CO2 + H+. The formate dehydrogenase-O does it in presence of oxygen, in other words:  under aerobic conditions. We can therefore avoid deleting fdoG simply because our bacteria will be used under anaerobic conditions. The formate dehydrogenase-N needs a source of nitrate to be active. In the laboratory, it is easy to work on medium which do not contain nitrogen and we can avoid deleting this gene. In reality, in a sewage treatment, this is much more problematic. But we can imagine that our bacteria will be used to produce hydrogen after the step of nitrogen removal. Deleting fdnG is necessary if we want to produce hydrogen in a medium which contain nitrogen. Especially when we  know that the formate dehydrogenase-N is a much more effective enzyme than the FHL system. Most of the formate will thus consume by the formate dehydrogenase-N instead of being transformed into hydrogen.</p>
+
       <p> <em>fdoG</em> encodes the formate dehydrogenase-O and <em>fdnG</em> the formate dehydrogenase-N. Those two formate dehydrogenase catalyze the transformation of formate into CO2 + H+. The formate dehydrogenase-O is active under aerobic conditions. We can therefore avoid deleting <em>fdoG</em> simply because our bacteria will be used under anaerobic conditions. The  formate dehydrogenase-N needs a source of nitrate to be active. In the laboratory, it is easy to work on a medium which does not contain nitrogen and we can avoid deleting this gene. In reality, in a sewage treatment facility, this could be much more problematic. We can propose that our bacteria will be used to produce hydrogen after the nitrogen removal step. Deleting <em>fdnG</em> would be necessary if we want to produce hydrogen in a medium that contains nitrogen. Moreover, the formate dehydrogenase-N is a much more effective enzyme than the FHL system. Most of the formate will thus be consumed by the formate dehydrogenase-N instead of being transformed into hydrogen.</p></ol>
-
<p>&nbsp;</p>
+
<p><gh2>Table  1</gh2>
-
<p><gh2>Table  1</gh2><br>
+
</p>
-
   All the sequences are  listed in the directionality 5’ -&gt; 3’.<br>
+
<p><br>
 +
   All the sequences are  listed in the directionality 5' -&gt; 3'.<br>
   <strong><u>PPC</u></strong><br>
   <strong><u>PPC</u></strong><br>
   H1<span style="background:yellow">R1</span>: ACCCTCGCGCAAAAGCACGAGGGTTTGCAGAAGAGGAAGA<span style="background:yellow">GTGTAGGCTGGAGCTGCTTC</span><br>
   H1<span style="background:yellow">R1</span>: ACCCTCGCGCAAAAGCACGAGGGTTTGCAGAAGAGGAAGA<span style="background:yellow">GTGTAGGCTGGAGCTGCTTC</span><br>
Line 184: Line 265:
   H2<span style="background:yellow">R2</span>: AGTAGCTTAAATGTGATTCAACATCACTGGAGAAAGTCTT<span style="background:yellow">CATATGAATATCCTCCTTA</span> <br>
   H2<span style="background:yellow">R2</span>: AGTAGCTTAAATGTGATTCAACATCACTGGAGAAAGTCTT<span style="background:yellow">CATATGAATATCCTCCTTA</span> <br>
   <strong><u>FocA</u></strong><br>
   <strong><u>FocA</u></strong><br>
-
   For FocA, we didn’t try to delete the entire gene because FocA is located next to pflB (one of the  genes useful for hydrogen production, see above). The RBS and the promoter of  pflB are included into the sequence of FocA. We decided to remove only the half  of FocA, leaving the RBS and promoter of pflB untouched.<br>
+
   For FocA, we didn't try to delete the entire gene because FocA is located next to pflB (one of the  genes useful for hydrogen production, see above). The RBS and the promoter of  pflB are included into the sequence of FocA. We decided to remove only the half  of FocA, leaving the RBS and promoter of pflB untouched.<br>
   H1<span style="background:yellow">R1</span>: GCTGCGGCCAGAATAACTCATCCATACTGCCAGACATACC<span style="background:yellow">GTGTAGGCTGGAGCTGCTTC</span> <br>
   H1<span style="background:yellow">R1</span>: GCTGCGGCCAGAATAACTCATCCATACTGCCAGACATACC<span style="background:yellow">GTGTAGGCTGGAGCTGCTTC</span> <br>
   H2<span style="background:yellow">R2</span>: GTTAGTATCTCGTCGCCGACTTAATAAAGAGAGAGTTAGT<span style="background:yellow">CATATGAATATCCTCCTTA</span> <br>
   H2<span style="background:yellow">R2</span>: GTTAGTATCTCGTCGCCGACTTAATAAAGAGAGAGTTAGT<span style="background:yellow">CATATGAATATCCTCCTTA</span> <br>
Line 192: Line 273:
   <strong><u>HybC</u></strong><br>
   <strong><u>HybC</u></strong><br>
   H1<span style="background:yellow">R1</span>: GTCAGCAAAATATTGCCGACCCCTAAGACTAAAATACGCA<span style="background:yellow">GTGTAGGCTGGAGCTGCTTC</span><br>
   H1<span style="background:yellow">R1</span>: GTCAGCAAAATATTGCCGACCCCTAAGACTAAAATACGCA<span style="background:yellow">GTGTAGGCTGGAGCTGCTTC</span><br>
-
  H2<span style="background:yellow">R2</span>: TAAAACAAAACGATCATAATCGTCATGAGGCGAGCAAAGC<span style="background:yellow">CATATGAATATCCTCCTTA</span> </p>
+
H2<span style="background:yellow">R2</span>: TAAAACAAAACGATCATAATCGTCATGAGGCGAGCAAAGC<span style="background:yellow">CATATGAATATCCTCCTTA</span> </p>
<p>&nbsp;</p>
<p>&nbsp;</p>
-
<p><gh2>References</gh2><br>
+
<p><gh2>References</gh2><br></p><p>
   [1]<a name="R1"></a> Maeda, T.; Sanchez-Torres, V.; K.  Wood, Thomas. - Enhanced hydrogen production from glucose by metabolically  engineered Escherichia coli - Appl Microbiol Biotechnol (2007) 77:879–890 –  September 2007.<br>
   [1]<a name="R1"></a> Maeda, T.; Sanchez-Torres, V.; K.  Wood, Thomas. - Enhanced hydrogen production from glucose by metabolically  engineered Escherichia coli - Appl Microbiol Biotechnol (2007) 77:879–890 –  September 2007.<br>
   [2]<a name="R2"></a> The  database Ecocyc for the bacterium <em>Escherichia coli</em> K-12 MG1655,  consulted online in July, August and September 2010: http://ecocyc.org/<br>
   [2]<a name="R2"></a> The  database Ecocyc for the bacterium <em>Escherichia coli</em> K-12 MG1655,  consulted online in July, August and September 2010: http://ecocyc.org/<br>

Latest revision as of 01:03, 28 October 2010

Introduction     Homologous recombination

Hydrogen production


E. coli naturally produces hydrogen through the mixed acid fermentation. Our goal in this part of the project is to increase the H2 production by modifying the carbon flow through the pathway of the mixed acid fermentation (MAF). The pathways of this fermentation are quite simple. Phosphoenolpyruvate (PEP), which is produced by the glycolysis, is transformed into pyruvate or into oxaloacetate. Those two molecules are then transformed into several products after a chain of reactions. Hydrogen is one of those products. It is produced from formate to regulate the intracellular pH of the bacteria [1].

Here is a simplified global overview of the mixed acid fermentation (fig.1):


Fig. 1 : Mixed acid fermentation pathway [2].

 Each reaction is controlled by one or several enzymes. By overexpressing or deleting specific genes of the MAF pathway, we expect to increase the hydrogen production. The part of MAF pathway in which we are interested is indicated by red lines (fig. 2).


Fig. 2: The interesting pathway for hydrogen production via the mixed acid fermentation.

All the reactions crossing the red lines should be avoided or limited, and the three main reactions which lead to hydrogen production should be increased. The hydrogen is produced from formate by the formate hydrogenase lyase system (FHL), an intracellular membrane-bound complex composed of the formate dehydrogenase (FDHH) and the hydrogenase 3 [1]. This complex catalyzes the following reaction:


Formate + H+ <=> H2 + CO2


Hydrogen is not excreted outside of the cell but it is immediately consumed by two uptake hydrogenases, the hydrogenase 1 and 2 [1][2]:


A menaquinone + H2 + 2H+ <=> A menaquinol + 2H+


The expression of the FHL system is activated at the level of transcription by the FhlA activator (formate hydrogen-lyase transcriptional activator). Expression of fhlA is positively regulated by FNR and repressed by HycA [1]. FNR is the main transcriptional regulator that mediates the transition between aerobic and anaerobic growth through the regulation of hundreds of genes [2]. All the regulations linked to the transformation of formate into hydrogen are shown here (fig.3):



Fig. 3 : Regulation of hydrogen production in E.coli [1].

 


MAF pathway modification: genes to delete


Several steps of the MAF pathway are irrelevant for hydrogen production (fig. 2). To inactivate these reactions, the genes encoding enzymes that catalyze these reactions have to be deleted using the technique described in the homologous recombination module. After exhaustive analyzes of the literature, we decided which genes we would overexpress and which we would disrupt. Here is the list of all the genes that we planned to delete. By using the KEIO Collection database, we checked that none of those genes were essential [4].

  • ppc

The ppc gene encodes the phosphoenolpyruvate carboxylase enzyme (Ppc). This enzyme catalyzes the following reaction [2]:


Phosphoenolpyruvate + CO2 + H2O <=> Oxaloacetate + Phosphate + H+


Deletion of the ppc gene will therefore prevent the PEP to be transformed into oxaloacetate which is not interesting for our application. As shown on figures 1 and 2, the left part of the MAF pathway does not lead to hydrogen production. Thus, deletion of ppc will inactivate this part of the pathway and all the PEP will be transformed into pyruvate.

  • ldhA

Pyruvate is transformed into (R)-lactate or into formate + acetyl-CoA. The second reaction is interesting for our application. The first reaction is mediated by the D-lactate dehydrogenase (LdhA) which catalyzes the following reaction:


NADH + Pyruvate + H+ <=> NAD+ + (R)-lactate


Deletion of ldhA should ensure that all the pyruvate is transformed into formate + acetyl-CoA.

  • focA

The focA gene encodes for a formate transporter located in the plasmic membrane. FocA transports formate outside the cell. It has been shown that disabling this transporter increases the intracellular formate concentration [5]. A higher formate intracellular concentration is obviously interesting for hydrogen production.

  • hyaB and hybC

To prevent hydrogen uptake by the two hydrogenases, HyaB and HybC, we have to inactivate them. Both hydrogenases-encoding genes are located in operons. The hya operon is composed of 6 genes (from hyaA to hyaF). The hyaB gene encodes the largest subunit of the hydrogenase [2]. This subunit is required for the hydrogenase to be functional [2]. Deleting this gene should inactivate the hydrogenase 1 [1].

The second hydrogenase-encoding gene is located in an operon composed of 7 genes (from hybA to hybG). The hybC gene encodes the largest subunit of the second hydrogenase. As for hyaB, deleting the gene encoding the largest subunit should inactivate it [1].

 

Materials and methods

 

  1. Gene deletion by the λ phage Red system
  2. In order to delete the five genes listed above, we used a method based on the λ phage Red system. As this method is described in great details in the ‘homologous recombination module’, we will briefly summarize it here. This method consists in the production of a gene-specific PCR fragment which contains an antibiotic resistance gene and site-specific recombination sites (FRT) flanking this gene. This PCR fragment is then electroporated in a strain containing the plasmid helper λ (PH λ) (see homologous recombination module). This plasmid encodes the genes of the Red system. The target gene is replaced by the resistance gene through homologous recombination using the Red system. We worked with two different antibiotic resistances: chloramphenicol (cm) and kanamicine (kan).
    The antibiotic resistance cassette is eventually removed by site-specific recombination using the Flp recombinase. This method leads to the ‘clean’ deletion of the gene of interest without any traces of antibiotic resistance gene. It is also adapted to delete genes in operons since the resistance-FRT cassettes used in this work also contain translation signal (RBS). This allows a proper expression of the genes downstream of the deletion (no polar effect). The primers used deleting the 5 genes of interest are listed in Table 1. 

  3. Phage P1 transduction
  4. P1vir stock :
    Overnight cultures of the donor strain are diluted 100 fold in 20 ml of LB medium supplemented with MgSO4 10-2M and of CaCl2 5.10-3M and grown at 37°C. At an optical density at 600nm of 0.2, 10µl of a P1 vir stock is added (approximately 109 pfu/ml). Once the bacteria are lysed, 1/20 (v/v) of chloroform is added and the culture is vigorously shacked. The mix is centrifuged at 4°C at 3,700 g and the supernatant is conserved at 4°C. 1/20 of the total volume of chloroform is added and vigorously shacked, then centrifuged again in the same conditions. The surnageant containing the P1 particles is stored at 4°C.
    P1vir transduction :
    Overnight culture of the recipient strain is pelleted and resuspended in the same volume of MgSO4 10-2M and of CaCl2 5.10-3M. To 100µl of the resuspended pellet, 100µl and 10µl of the P1 lysat is added. The mix is conserved 30 min at 37°C. 3 ml of agar 0.7% is added as well as 100µl of Na citrate 1M. The entire mix is plated on selective plates at 37°C for 16h. The candidates are streaked 3 times on selective plates and a PCR is then performed to confirm the transduction of the marker of interest. 

 


Results

 

  • Deletion of the ldhA gene by homologous recombination

  • The amplification of the resistance cassettes with the primers specific to our 5 genes of interest by PCR took us a little more than a week. Because of the size of the primers used, we had to try several times the PCR and vary the parameters.
    Here is the picture of the electrophoresis of those PCR for the 5 genes:


    For each genes we tried to obtain both chloramphenicol (about 1100bp) and kanamicine (about 1500bp) resistance cassettes. From left to right we have the genes ldhA (1 and 2), focA (4 and 5), ppc (7 and 8), hybC (10 and 11) and hyaB (13 and 14). The sinks 3, 6, 9, 12 and 15 are the five negative controls.
            Once we obtained these cassettes, it took us about 1 month to obtain our first deletion candidate. The electroporation efficiency of the MG1655/PHl strain was not good. We obtained a lot of false-positive deletion candidates (i.e. clones growing on the selective medium). As explained in the homologous recombination module, we had to purify at least three times each candidate (this process takes therefore at least 3 days) before checking the deletion/insertion of the resistance cassette. Using primers complementary to the flanking regions of the genes of interest, PCR were performed on candidate colonies (data shown below). Unfortunately, the candidates were most of the time wild-type for the gene of interest. Our hypothesis is that the resistance cassette was inserted at another location in the genome. The reason for that is unknown since the genes of interest are not essential for E. coli viability, at least in the conditions we used. 
    After several weeks of unsuccessful attempts, we finally obtained the MG1655 DldhA::cm strain. Here is the picture of the electrophoresis where we tested different deletion candidates:


    The sinks we are interested in are the 4 first ones. The wild type version of the gene ldhA is in the third sink. The two first sinks are the deletion candidates for ldhA with the cm resistance cassette. The fourth sink is the negative control for this gene. For information, the other sinks are the tests for the 4 other genes: 5 and 6 are the deletion candidates for ppc; 9 and 10 are the deletion candidates for focA; 17 and 18 are the deletion candidates for hybC: 21 and 22 are the deletion candidates for hyaB. Unfortunately, the cm resistance cassette (about 1100 bp) and the gene ldhA (990 bp) have approximately the same length. In order to testify if we really had the MG1655 DldhA::cm strain, we did a test with a restriction enzyme which cut the gene ldhA.
    The result of this test is shown here:


    After the purification process, we had 4 candidates for the MG1655 DldhA::cm strain. For those 4 candidates, we did a PCR on the gene ldhA (not knowing if it really was ldhA or the cm resistance cassette that we amplified) and we digest the product of the PCR with an enzyme which cut ldhA. The digested gene ldhA is in the sink 7, the digested cm resistance cassette is in the sink 6. The four digested candidates are in the 4 first sinks. The result is therefore a success, because the candidates are not digested like ldhA. The wild-type version of the gene has been successfully replaced with the cm resistance cassette. We have our MG1655 DldhA::cm strain.

    • Construction of the MG1655 Dppc::kan, MG1655 DfocA::kan, MG1655 DhyaB::kan, MG1655 DldhA::cm Dppc::kan, MG1655 DldhA::cm DfocA::kan andMG1655 DldhA::cm DhyaB::kan mutant strains by P1 transduction

    By that time, we obtained the KEIO strains deleted for our 5 genes of interest. We were thus able to make a P1 stock on these strains (see materials and methods) and to transduce the Dppc::kan, DfocA::kan, DhyaB::kan and DhybC::kan markers in the MG1655 wild-type strain and in the MG1655 DldhA::cm strain. We obtained 6 mutant strains: the single MG1655 Dppc::kan, MG1655 DfocA::kan and MG1655 DhyaB::kan mutant strains as well as the double MG1655 DldhA::cm Dppc::kan, MG1655 DldhA::cm DfocA::kan andMG1655 DldhA::cm DhyaB::kan mutant strains.  These strains were checked by PCR. 
    The results are shown here:


     

    For each strain tested, we have: four candidates, one negative control and the wild type version of the gene that is supposed to have been deleted. If the amplified DNA segment of a candidate has the size of the reistance cassette instead of the size of the wild type version of the gene, the candidate is a mutant. Here are the results:

    • From 1 to 6 is the test for the MG1655 DhyaB::kan mutant: the 4 candidates are mutants.
    • From 8 to 13 is the test for the MG1655 DldhA::kan mutant: the candidates in the sinks 10 and 11 are mutants.
    • From 17 to 22 is the test for the gene ldhA of the double MG1655 DldhA::cm Dppc::kan mutant: the 4 candidates are mutants.
    • From 24 to 29 is the test for the gene ldhA of the double MG1655 DldhA::cm DfocA::kan mutant: the 4 candidates are mutants.
    • From 33 to 38 is the test for the gene focA of the double MG1655 DldhA::cm DfocA::kan mutant: the candidates in the sinks 35 and 36 are mutants.
    • From 40 to 45 is the test for the gene ppc of the double MG1655 DldhA::cm Dppc::kan mutant: the candidates in the sinks 40, 42 and 43 are mutants.

            We managed to obtain different double mutant strains, ready for another transduction. Unfortunately, due to the lack of time we were unable to continue our progression and we were also unable to characterize the double mutant strains for growth in different medium, at different temperature, …

     


    MAF pathway modification: Genes to overexpress

     

    In order to enhance hydrogen production, we proposed to over-express some genes involved in the hydrogen production. Three steps in the mixed acid fermentation pathway are of interest:

    • The transformation of phosphoenolpyruvate into pyruvate:

    Phosphoenolpyruvate + ADP + 2H+ <=> Pyruvate + ATP

    This reaction is present in other pathway. We thus decided not to improve it assuming it will not be the limiting step.

    • The transformation of pyruvate into formate:

    Pyruvate + Coenzyme A <=>  Formate + Acetyl-CoA

    This reaction is catalyzed by two pyruvate formate lyase: PflB and TdcE. The formate is the key molecule for hydrogen production and intracellular elevated formate concentration is needed for an efficient hydrogen production [6].

    • The transformation of formate into hydrogen:

    Formate + H+ <=>  CO2 + H2

    This reaction is under the control of the FHL complex (formate hydrogenase lyase composed of the formate dehydrogenase (FDHH) and the hydrogenase 3). As stated above, the FHL complex is regulated by FNR, a transcriptional regulator that mediates the transition between aerobic and anaerobic growth, and repressed by HyaC. It has been showed that FHL activity is not the limiting step for hydrogen production. We decided not to over-express the two enzymes of the FHL complex [3].
    On the basis of these three reactions, we decided to overexpress the following genes:

    • fnr

            fnr is quite an obvious choice for the first gene to overexpress. FNR is the main transcriptional regulator that mediates the transition from aerobic to anaerobic growth [2]. The concentration of the FNR protein is similar under aerobic and anaerobic conditions. The regulation occurs at the level of FNR activity: in the presence of O2, FNR is inactivated. Under anaerobic conditions, FNR is functional and activates expression of hundreds of genes involved in anaerobic metabolism. In these conditions, FNR represses genes involved in aerobic metabolism [2]. Over-expressing the fnr gene should increase FNR concentration and should thus enhance the anaerobic metabolism. The three reactions of the mixed acid fermentation pathway leading to hydrogen described above should therefore be increased.

    • pflB

            The pflB gene encodes one of the two pyruvate formate lyases which catalyze the transformation of pyruvate into formate [2]. This reaction is the most important one for hydrogen production. Over-expressing pflB should increase formate concentration and therefore hydrogen production. Although pyruvate is the substrate for many other reactions, high level of PflB should direct pyruvate to formate synthesis and therefore hydrogen production.

    • tdcE

    The tdcE gene encodes the second pyruvate formate lyase [2]. The reasons to overexpress this gene are the same as for pflB.

    Materials and methods


    To over-express these three genes of interest, we decided to insert them into plasmid pSB1C3 with a strong RBS, a constitutive promoter and a terminator. We decided to work in the BioBrick standard assembly 10 because it is compatible with pSB1C3. 
    First of all, we had to obtain the three genes to ligate them with the RBS, the promoter and the terminator. Unfortunately, the fnr gene contains an EcoR1 restriction site. Therefore, we had to introduce a silent mutation in the sequence of this restriction site and ordered the modified fnr on mrgene.com.
    The tdcE gene was obtained by PCR using specific primers and the wild-type genome of E. coli.
    The pflB sequence contains a restriction enzyme present in the standard assembly 10: Pst1. We could have also introduced a silent mutation in this sequence and ordered it on mrgene.com. However, due to the size of the pflb gene (2283 bp) and our limited budget, we were not able to afford it.
    The RBS, the promoter and the terminator that were selected are the same for the three genes and are described as being the ‘strongest’ ones received in spring 2010 distribution.
    The promoter is: BBa_J23100
    The RBS is: BBa_B0034
    The terminator is: BBa_B0024
    After obtaining the gene sequences either by PCR or by in vitro synthesis, the plan was to ligated them into the plasmid containing the RBS opened with Spe1 and Pst1 in order to clone the genes downstream of the RBS. The genes were also digested by Xba1 and Pst1. The second step was to ligate the part RBS + gene with the promoter. The third step consisted in extracting the construction promoter + RBS + gene and inserting upstream of the terminator. The last step was to extract the promoter+RBS+gene+terminator and insert it into the pSB1C3 plasmid.
    Unfortunately, due to lack of time, we were unable to do all these constructs.
    We managed to obtain the gene tdcE by PCR as we can see here:


    The gene tdcE is in the sink 3 and 5. The two sinks correspond to two different PCR programs. The sinks 2 and 4 are the negative controls for those PCR.
               We digested tdcE and inserted it in the pSB1C3 to send it as a BioBrick: BBa_K348000.


    Genes of the MAF pathway that we did not consider

     

    Several other genes of the MAF pathway could have been potential candidates for modifications (deletion or overexpression). However, after exhaustive literature readings, we did not consider them. 

    1. hycA
    2.         This gene encodes HycA, a regulator of the hydrogenase 3 in the FHL system [2]. This regulator limits the amount of hydrogenase 3 in the cell. Deleting hycA should therefore lead to an increase of the concentration of hydrogenase 3. Note that as stated above, the hydrogenase 3 catalyzes the transformation of formate into hydrogen. We did not consider this candidate since transformation of formate into hydrogen do not appear to be the limiting step for hydrogen production and normal concentration of hydrogenase 3 is fully adequate[3].

    3. aceE
    4.         This gene encodes a subunit of the pyruvate dehydrogenase complex. This complex catalyzes the following reaction [2]:
      Pyruvate + NAD+ + coenzyme A <=> Acetyl-CoA + CO2 + NADH
      For hydrogen production, transformation of pyruvate into formate is needed. The AceE enzyme catalyzes a variety of reactions, and deleting the corresponding gene reduces E. coli viability [1]. We therefore decided not to delete this gene. We focused on the transformation of pyruvate into formate and to overexpress the tdcE gene (see above).

    5. poxB
    6.         The poxB gene encodes a pyruvate oxydase, which catalyzes the transformation of pyruvate into acetate and CO2 [1]. It has been described that deleting poxB does not increase hydrogen production [1].

    7. focB
    8.         FocB is a formate transporter (the other formate transporter is FocA, see above). Unlike FocA, FocB is less efficient and less specific to formate. We could have deleted focB as well but deleting the two formate transporter would have reduced the growth rate[1].

    9. fdoG and fdnG
    10.        

      fdoG encodes the formate dehydrogenase-O and fdnG the formate dehydrogenase-N. Those two formate dehydrogenase catalyze the transformation of formate into CO2 + H+. The formate dehydrogenase-O is active under aerobic conditions. We can therefore avoid deleting fdoG simply because our bacteria will be used under anaerobic conditions. The formate dehydrogenase-N needs a source of nitrate to be active. In the laboratory, it is easy to work on a medium which does not contain nitrogen and we can avoid deleting this gene. In reality, in a sewage treatment facility, this could be much more problematic. We can propose that our bacteria will be used to produce hydrogen after the nitrogen removal step. Deleting fdnG would be necessary if we want to produce hydrogen in a medium that contains nitrogen. Moreover, the formate dehydrogenase-N is a much more effective enzyme than the FHL system. Most of the formate will thus be consumed by the formate dehydrogenase-N instead of being transformed into hydrogen.

    Table 1


    All the sequences are listed in the directionality 5' -> 3'.
    PPC
    H1R1: ACCCTCGCGCAAAAGCACGAGGGTTTGCAGAAGAGGAAGAGTGTAGGCTGGAGCTGCTTC
    H2R2: ACAGGGCTATCAAACGATAAGATGGGGTGTCTGGGGTAATCATATGAATATCCTCCTTA
    LdhA
    H1R1: ATCTGAATCAGCTCCCCTGGAATGCAGGGGAGCGGCAAGAGTGTAGGCTGGAGCTGCTTC
    H2R2: AGTAGCTTAAATGTGATTCAACATCACTGGAGAAAGTCTTCATATGAATATCCTCCTTA
    FocA
    For FocA, we didn't try to delete the entire gene because FocA is located next to pflB (one of the genes useful for hydrogen production, see above). The RBS and the promoter of pflB are included into the sequence of FocA. We decided to remove only the half of FocA, leaving the RBS and promoter of pflB untouched.
    H1R1: GCTGCGGCCAGAATAACTCATCCATACTGCCAGACATACCGTGTAGGCTGGAGCTGCTTC
    H2R2: GTTAGTATCTCGTCGCCGACTTAATAAAGAGAGAGTTAGTCATATGAATATCCTCCTTA
    HyaB
    H1R1: CAGAAACCGAACATCAGCCAGGCAATGAGGATAAACAGGCGTGTAGGCTGGAGCTGCTTC
    H2R2: CGTTGTCGCTTTTCTGTTGCATGATGATTCTCCTTCGCTGCATATGAATATCCTCCTTA
    HybC
    H1R1: GTCAGCAAAATATTGCCGACCCCTAAGACTAAAATACGCAGTGTAGGCTGGAGCTGCTTC
    H2R2: TAAAACAAAACGATCATAATCGTCATGAGGCGAGCAAAGCCATATGAATATCCTCCTTA

     

    References

    [1] Maeda, T.; Sanchez-Torres, V.; K. Wood, Thomas. - Enhanced hydrogen production from glucose by metabolically engineered Escherichia coli - Appl Microbiol Biotechnol (2007) 77:879–890 – September 2007.
    [2] The database Ecocyc for the bacterium Escherichia coli K-12 MG1655, consulted online in July, August and September 2010: http://ecocyc.org/
    [3] Node, K.; Watanabe, M.; Makimoto, H.; Tomiyama, M. - Effect of hydrogenase 3 over-expression and disruption of nitrate reductase on fermamentive hydrogen production in Escherichia coli

    [4] The KEIO Collection consulted online in July, August and September 2010: http://ecoli.naist.jp/gb6/Resources/deletion/deletion.html

    [5] Suppmann, B.; Sawers, G. - Isolation and characterization of hypophosphite--resistant mutants of Escherichia coli: identification of the FocA protein, encoded by the pfl operon, as a putative formate transporter - Lehrstuhl für Mikrobiologie der Universität München, Germany. - Mol Microbiol. 1994 Mar;11(5):965-982. – March 1994.

    [6] Sawers, R.G. - Formate and its role in hydrogen production in Escherichia coli - Biochemical Society Transactions (2005) Volume 33, part 1 – Pages 42-46 – September 2004.

    Introduction     Homologous recombination